User:Pakpoom Subsoontorn/Notebook/Genetically Encoded Memory/2008/10/28: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Line 12: Line 12:
length:: 613 aa
length:: 613 aa
crystal structure is unknown.
crystal structure is unknown.
*Target sequence: attB:: has two inverted repeated sequence (core-type) flanking an overlap region (TTG). Minimal attB is 34 bps while minimal attP is 39 bp for e.coli intramolecular integration.  
*Target sequence: attB:: has two inverted repeated sequence (core-type) flanking an overlap region (TTG). Minimal attB is 34 bps while minimal attP is 39 bp for e.coli intramolecular integration. attP:: has core-type sites and overlap region, without an arm-type site. --See the schematic sequence of attB and attP at (1-f1). See Groth-2000 for experiment for minimal sequence. --See Thyagarajan-2001 for integration of attB and attP above background/pseudointegration site ~attP in human genome  (these could be very cool model experiment!)
attP:: has core-type sites and overlap region, without an arm-type site
 
*Change specificity:
*Change specificity:
Mutation/directed evolution could change specificity to pseudo attP site (HpsA, 44% identity)
Mutation/directed evolution could change specificity to pseudo attP site (HpsA, 44% identity)
Line 19: Line 19:
*Excision:
*Excision:
Excisionase has not yet been found.
Excisionase has not yet been found.
*Usage:
 
Integration works in E.coli, mammalian and in vitro
*mutant/hybrid
**directed evolution for targeting human's site
 
*Non-natural host:
**Integration works in E.coli, mammalian and in vitro,
**Mouse embryos Hollis et al 2003
**Bovine fiboblase--Ma et al 2006
**Drosophila--Groth et al 2004
**Aedes aegyptus--Nimmo et al 2006
**Silk worm--Nakayama et al 2006
**cassette exchange: Drosphila --Bateman et al 2006, fission yeast--Thomson et al 2001, mouse embryonic stem cell--Belteki et al 2003
**Xenopus laevis--Allen&Weeks 2005
**chloroplast transformation--Lutz et al 2004
*gene therapy example--table1 for ref-1




==References==
*1Calos MP. The PhiC31 Integrase System for Gene Therapy. Current gene Therapy, 2006, 6, 633-645.
<!-- ##### DO NOT edit below this line unless you know what you are doing. ##### -->
<!-- ##### DO NOT edit below this line unless you know what you are doing. ##### -->
|}
|}


__NOTOC__
__NOTOC__

Revision as of 03:11, 12 November 2008

Project name <html><img src="/images/9/94/Report.png" border="0" /></html> Main project page
<html><img src="/images/c/c3/Resultset_previous.png" border="0" /></html>Previous entry<html>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</html>Next entry<html><img src="/images/5/5c/Resultset_next.png" border="0" /></html>

PhiC31

  • Host: Streptomyces lividans
  • Action: tyrosine integrase
  • Structure:

length:: 613 aa crystal structure is unknown.

  • Target sequence: attB:: has two inverted repeated sequence (core-type) flanking an overlap region (TTG). Minimal attB is 34 bps while minimal attP is 39 bp for e.coli intramolecular integration. attP:: has core-type sites and overlap region, without an arm-type site. --See the schematic sequence of attB and attP at (1-f1). See Groth-2000 for experiment for minimal sequence. --See Thyagarajan-2001 for integration of attB and attP above background/pseudointegration site ~attP in human genome (these could be very cool model experiment!)
  • Change specificity:

Mutation/directed evolution could change specificity to pseudo attP site (HpsA, 44% identity)

  • Mechanism:
  • Excision:

Excisionase has not yet been found.

  • mutant/hybrid
    • directed evolution for targeting human's site
  • Non-natural host:
    • Integration works in E.coli, mammalian and in vitro,
    • Mouse embryos Hollis et al 2003
    • Bovine fiboblase--Ma et al 2006
    • Drosophila--Groth et al 2004
    • Aedes aegyptus--Nimmo et al 2006
    • Silk worm--Nakayama et al 2006
    • cassette exchange: Drosphila --Bateman et al 2006, fission yeast--Thomson et al 2001, mouse embryonic stem cell--Belteki et al 2003
    • Xenopus laevis--Allen&Weeks 2005
    • chloroplast transformation--Lutz et al 2004
  • gene therapy example--table1 for ref-1


References

  • 1Calos MP. The PhiC31 Integrase System for Gene Therapy. Current gene Therapy, 2006, 6, 633-645.